Details for New Drug Application (NDA): 217442
✉ Email this page to a colleague
The generic ingredient in LISDEXAMFETAMINE DIMESYLATE is lisdexamfetamine dimesylate. Fifteen suppliers are listed for this compound. Additional details are available on the lisdexamfetamine dimesylate profile page.
Summary for 217442
Tradename: | LISDEXAMFETAMINE DIMESYLATE |
Applicant: | Ascent Pharms Inc |
Ingredient: | lisdexamfetamine dimesylate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 217442
Physiological Effect | Central Nervous System Stimulation |
Medical Subject Heading (MeSH) Categories for 217442
Suppliers and Packaging for NDA: 217442
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LISDEXAMFETAMINE DIMESYLATE | lisdexamfetamine dimesylate | CAPSULE;ORAL | 217442 | ANDA | Ascent Pharmaceuticals, Inc. | 43602-306 | 43602-306-01 | 100 CAPSULE in 1 BOTTLE (43602-306-01) |
LISDEXAMFETAMINE DIMESYLATE | lisdexamfetamine dimesylate | CAPSULE;ORAL | 217442 | ANDA | Ascent Pharmaceuticals, Inc. | 43602-307 | 43602-307-05 | 500 CAPSULE in 1 BOTTLE (43602-307-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
Approval Date: | Aug 25, 2023 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 20MG | ||||
Approval Date: | Aug 25, 2023 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 30MG | ||||
Approval Date: | Aug 25, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription